Page 15 - Pharmaceutical

Mylan agrees for $ 465-mn settlement with US DoJ for EpiPen auto-injector

The company has agreed for the payment to resolve questions that have been raised about the classification of EpiPen auto-injector for purposes of the Medicaid Drug Rebate Program

Dr Reddy's Labs forays into Colombia

The company will launch its portfolio of high quality and affordable medicines for cancer patients in the Colombian pharmaceutical market

Indian biosimilars market to reach $ 40 bn by 2030: Study

With a new regulatory policy and increased affordability offered by biosimilars, the domestic market is expected to grow at an accelerated pace, says a Assocham-Sathguru Management report

Lupin to use MonoSol technology for developing paediatric products

The Mumbai-headquartered will develop multiple paediatric products utilising the US-based MonoSol Rx's proprietary PharmFilm drug delivery technology

Zydus to market immunosuppressant drug of Switzerland's Neovii in India

The company has inked in-licensing pact with Swiss firm for the launches Grafalon, an immunosuppressant extensively used in solid organ transplants and stem cell transplant

Jubilant's lyophilised kit for radiopharmaceuticals receives Australian approval

The company has received TGA's nod for lyophilised kit for the preparation of Technetium 99m Macro-Aggregated Albumin (MAA) injection

Emergent BioSolutions bags $1.6 bn contract for anthrax vaccine in US

The company was awarded the contract by the Biomedical Advanced Research and Development Authority (BARDA) for advanced development & delivery of NuThrax vaccine

AbbVie opens small molecule API facility in Singapore

The facility, which marks AbbVie's first manufacturing presence in Asia, is the first phase of the project to develop a production site in Singapore which will also house a biologics facility

US FDA issues thirteen 483 observations for Alkem's Daman facility

Observations were issued to the company following US drug regulator's inspection at its manufacturing facility at Daman from September 20 to September 29, 2016

Non-availability of D-penicillamine disrupts Panacea Biotec's Cilamin capsule supply

The company, which recently released limited quantities of the medicine in the market, is holding talks with Indian and China raw material suppliers to normalise the situation

Systech eyes growth in Indian pharma sector as traceability gains traction

With developed countries enacting stringent serialisation and tracing regulations, the company aims to capitalise on India's booming pharmaceutical market

Kilitch Drugs allotted land in Ethiopia to set up production facility

The company has been looking to expand its presence in Africa with plans to set up manufacturing facilities in Ethiopia and Burkina Faso primarily for nutraceuticals

Suven Life secures patents for CNS drug in India and Japan

These patents are valid through 2026 and 2032 in India and Japan, respectively

Syngene closes deal to buy Strand Life's bioinformatics platforms

The deal to boost Syngene's bioinformatics and data analytics capabilities

Indoco Remedies buys Micro Labs' manufacturing facility in Baddi

The acquired facility, which produces 4.3 billion tablets and 50 million capsules per annum, is close to Indoco's existing manufacturing plant in Baddi

Suresh Subramanian to head Biocon's branded formulations business in India

He has over 30 years of experience in the pharmaceuticals market, having worked in India and Thailand for MNCs such as GlaxoSmithKline, Novartis, AstraZeneca and Pfizer

Zydus partners with Japan's Takeda to develop vaccine for chikungunya

Early stage project will develop a vaccine for chikungunya, for which there is currently no vaccine or medicine to treat it

Glenmark inks pact with Lubrizol arm Particle Sciences to develop generic cancer drug

As per the deal, Glenmark will have global exclusive marketing rights of the product - a generic version of cancer drug Abraxane that had worldwide sales of $ 967 million in 2015

Themis Medicare joins hand with Nevakar to tap US pharma market

As per the deal, Themis will develop a selected number of injectable products that will be manufactured and commercialised by Nevakar in the US and select global markets

Horizon Pharma buys Raptor Pharmaceutical for $ 800 million

The deal will strengthen Irish firm's focus on rare diseases and expand its operations in Europe and other international markets